Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation

被引:83
作者
Loren, A. W. [1 ]
Porter, D. L. [1 ]
机构
[1] Univ Penn, Abramson Canc Ctr, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
关键词
acute leukemia; graft-versus-leukemia; donor lymphocyte infusions;
D O I
10.1038/sj.bmt.1705898
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Allogeneic stem cell transplantation (SCT) offers the only hope for cure for many adults with acute leukemia. Unfortunately, many patients relapse and die of their disease even after transplantation. Although in some cases, allogeneic SCT is effective because the intensive conditioning therapy eradicates all malignant cells, it has long been recognized that the adoptive transfer of donor immunity plays a critically important role in the induction and maintenance of remission. Recognition of the graft-versus-leukemia (GVL) effect of allogeneic SCT has prompted attempts at remission re-induction by adoptive immunotherapy with donor lymphocyte infusions (DLIs) in patients with relapsed disease after allogeneic SCT. In some cases, DLI-induced remissions are sustained and patients cured when no other treatment modality was effective. This review discusses the rationale, biology, complications and future applications of DLI in acute leukemia patients after allogeneic SCT.
引用
收藏
页码:483 / 493
页数:11
相关论文
共 99 条
[1]   Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion [J].
Akpek, G ;
Boitnott, JK ;
Lee, LA ;
Hallick, JP ;
Torbenson, M ;
Jacobsohn, DA ;
Arai, S ;
Anders, V ;
Vogelsang, GB .
BLOOD, 2002, 100 (12) :3903-3907
[2]   Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation [J].
Alessandrino, EP ;
Bernasconi, P ;
Caldera, D ;
Colombo, A ;
Malcovati, L ;
Martinelli, G ;
Bonfichi, M ;
Pagnucco, G ;
Salvaneschi, L ;
Bernasconi, C .
BONE MARROW TRANSPLANTATION, 1999, 23 (06) :607-612
[3]   Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant [J].
Alyea, EP ;
Soiffer, RJ ;
Canning, C ;
Neuberg, D ;
Schlossman, R ;
Pickett, C ;
Collins, H ;
Wang, YL ;
Anderson, KC ;
Ritz, J .
BLOOD, 1998, 91 (10) :3671-3680
[4]   Stem cell transplantation-harnessing of graft-versus-malignancy [J].
Antin, JH .
CURRENT OPINION IN HEMATOLOGY, 2003, 10 (06) :440-444
[5]   Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings [J].
Antin, JH ;
Childs, R ;
Filipovich, AH ;
Giralt, S ;
Mackinnon, S ;
Spitzer, T ;
Weisdorf, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (09) :473-485
[6]   Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation [J].
Atanackovic, Djordje ;
Arfsten, Julia ;
Cao, Yanran ;
Gnjatic, Sacha ;
Schnieders, Frank ;
Bartels, Katrin ;
Schilling, Georgia ;
Faltz, Christiane ;
Wolschke, Christine ;
Dierlamm, Judith ;
Ritter, Gerd ;
Eiermann, Thomas ;
Hossfeld, Dieter Kurt ;
Zander, Axel R. ;
Jungbluth, Achim A. ;
Old, Lloyd J. ;
Bokemeyer, Carsten ;
Kroeger, Nicolaus .
BLOOD, 2007, 109 (03) :1103-1112
[7]   TREATMENT OF MURINE LEUKAEMIA WITH X-RAYS AND HOMOLOGOUS BONE MARROW .2. [J].
BARNES, DWH ;
LOUTIT, JF .
BRITISH JOURNAL OF HAEMATOLOGY, 1957, 3 (03) :241-252
[8]   TREATMENT OF MURINE LEUKAEMIA WITH X-RAYS AND HOMOLOGOUS BONE MARROW - PRELIMINARY COMMUNICATION [J].
BARNES, DWH ;
CORP, MJ ;
LOUTIT, JF ;
NEAL, FE .
BRITISH MEDICAL JOURNAL, 1956, 2 (SEP15) :626-627
[9]   Blood or marrow? [J].
Bensinger, WI ;
Deeg, HJ .
LANCET, 2000, 355 (9211) :1199-1200
[10]   Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia [J].
Berthou, C ;
Léglise, MC ;
Herry, A ;
Balcon, D ;
Hardy, E ;
Lessard, M ;
Abgrall, JF .
LEUKEMIA, 1998, 12 (11) :1676-1681